Stericycle (NASDAQ:SRCL) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Stericycle (NASDAQ:SRCL) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the business services provider’s stock.

A number of other brokerages have also recently issued reports on SRCL. Royal Bank of Canada reaffirmed a sector perform rating and set a $62.00 target price (down previously from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Truist Financial raised their target price on shares of Stericycle from $50.00 to $62.00 and gave the company a hold rating in a research note on Tuesday, June 4th. Finally, Keefe, Bruyette & Woods lifted their target price on shares of Stericycle from $135.00 to $142.00 and gave the stock an outperform rating in a report on Tuesday, June 4th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of Hold and a consensus price target of $74.00.

Stericycle Stock Up 0.4 %

Stericycle stock opened at $59.30 on Friday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55. Stericycle has a 1-year low of $37.78 and a 1-year high of $59.45. The firm’s fifty day simple moving average is $58.56 and its 200-day simple moving average is $54.02. The company has a market capitalization of $5.51 billion, a P/E ratio of -269.55, a P/E/G ratio of 3.23 and a beta of 1.11.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.04. The company had revenue of $661.60 million for the quarter, compared to analyst estimates of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. Sell-side analysts forecast that Stericycle will post 2.29 earnings per share for the current fiscal year.

Institutional Trading of Stericycle

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Clearstead Trust LLC bought a new stake in shares of Stericycle in the first quarter valued at about $25,000. International Assets Investment Management LLC bought a new stake in shares of Stericycle in the 2nd quarter worth approximately $45,000. GAMMA Investing LLC grew its holdings in shares of Stericycle by 170.9% during the 1st quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock worth $43,000 after purchasing an additional 516 shares in the last quarter. Principal Securities Inc. bought a new stake in shares of Stericycle during the fourth quarter valued at approximately $41,000. Finally, Headlands Technologies LLC bought a new stake in shares of Stericycle during the first quarter valued at approximately $44,000. 98.82% of the stock is currently owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.